跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nadixa - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nadixa
Approved
STANDARD
Nadixa
Ferrer Internacional, S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7668a794350f0080
Company
Ferrer Internacional, S.A.
Type
Standard
Approval Details
Approval Id
7668a794350f0080
Drug Approval Philippines Name
Nadixa
Product Name
Nadixa
Registration Number
DR-XY45858
Brand Name
Nadixa
Generic Name
Nadifloxacin
Dosage Form
Cream
Dosage Strength
10 mg/g (1% w/w)
Manufacturer
Ferrer Internacional, S.A.
Importer
Metro Pharma Philippines, Inc.
Distributor
Metro Pharma Philippines, Inc.
Company Detail Path
/organization/ferrer-internacional-s-a
Issuance Date
28 March 2022
Expiry Date
12 April 2027
Pharmacologic Category
Antibacterial (Fluoroquinolone)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7668a794350f0080
Type
Standard
Back to Philippines FDA Approvals